Published in Cancer on December 15, 2001
Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors. Cancer (2008) 1.24
Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. World J Gastroenterol (2003) 0.96
β-Catenin and K-RAS synergize to form primitive renal epithelial tumors with features of epithelial Wilms' tumors. Am J Pathol (2011) 0.94
Phase I and pharmacokinetic study of cetuximab and irinotecan in children with refractory solid tumors: a study of the pediatric oncology experimental therapeutic investigators' consortium. J Clin Oncol (2009) 0.84
High cyclin E staining index in blastemal, stromal or epithelial cells is correlated with tumor aggressiveness in patients with nephroblastoma. PLoS One (2008) 0.82
KIT, PDGFRalpha and EGFR analysis in nephroblastoma. Virchows Arch (2008) 0.82
Association between the HER2 expression and histological differentiation in Wilms tumor. Pediatr Surg Int (2006) 0.81
Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours. BMC Cancer (2011) 0.79
Inheritance of susceptibility to induction of nephroblastomas in the Noble rat. Differentiation (2009) 0.77
The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful? World J Urol (2011) 0.76
Her2/neu Expression in Wilms' Tumor and Correlation With Histopathologic Findings. Iran J Cancer Prev (2013) 0.75
The first investigation of Wilms' tumour atomic structure-nitrogen and carbon isotopic composition as a novel biomarker for the most individual approach in cancer disease. Oncotarget (2016) 0.75
Biomarkers for Wilms Tumor: A Systematic Review. J Urol (2016) 0.75
Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res (1998) 2.10
In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin. Prostate (1995) 2.07
Characterization of a zinc-finger protein and its association with apoptosis in prostate cancer cells. J Natl Cancer Inst (2000) 1.78
Marker chromosomes in a series of 10,000 prenatal diagnoses. Cytogenetic and follow-up studies. Prenat Diagn (1987) 1.70
Adrenal glands of mouse and rat do not synthesize androgens. Life Sci (1992) 1.64
Development of seven new human prostate tumor xenograft models and their histopathological characterization. Am J Pathol (1996) 1.29
Staging prostate cancer. Microsc Res Tech (2000) 1.20
Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteins. Eur J Cancer (1999) 1.16
Differentially expressed genes in androgen-dependent and -independent prostate carcinomas. Cancer Res (1997) 1.11
Bladder calculi in augmentation cystoplasty in children. Urology (2000) 1.08
Satisfaction with penile appearance after hypospadias surgery: the patient and surgeon view. J Urol (1996) 1.08
Psychosexual adjustment of children and adolescents after different types of hypospadias surgery: a norm-related study. J Urol (1995) 1.07
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection. Br J Dermatol (2003) 1.07
Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. J Urol (2000) 1.05
Effect of culture conditions on androgen sensitivity of the human prostatic cancer cell line LNCaP. Prostate (1993) 1.05
Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer (2003) 1.01
EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene (2000) 0.99
Effects of low testosterone levels and of adrenal androgens on growth of prostate tumor models in nude mice. J Steroid Biochem Mol Biol (1990) 0.98
Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancer. J Pathol (2002) 0.97
Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice. Prostate (1993) 0.97
Vanished testis: be aware of an abdominal testis. J Urol (2000) 0.96
Expression of multidrug resistance related proteins and proliferative activity is increased in advanced clinical prostate cancer. J Urol (2001) 0.94
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy. Clin Cancer Res (1997) 0.94
Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation. Cancer Res (2000) 0.94
Expression of platelet-derived growth factor (PDGF) and PDGF receptors in human malignant mesothelioma in vitro and in vivo. J Pathol (1996) 0.93
Antenatal hydronephrosis: changing concepts in diagnosis and subsequent management. BJU Int (2000) 0.93
Recoverability of renal function after relief of chronic partial upper urinary tract obstruction. BJU Int (1999) 0.93
Neuroendocrine differentiation in human prostatic tumor models. Am J Pathol (1996) 0.92
Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J Clin Pathol (2003) 0.92
Neutrons and X-rays, comparative studies with Drosophila melanogaster. 1. The viability and fertility of induced autosomal translocations. Mutat Res (1981) 0.91
Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer (1999) 0.90
Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma. Clin Cancer Res (2000) 0.90
Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension. Exp Hematol (1981) 0.90
Decreased levels of topoisomerase II alpha in human renal cell carcinoma lines resistant to etoposide. J Cancer Res Clin Oncol (1997) 0.89
The use of steroid-containing Silastic implants in male nude mice: plasma hormone levels and the effect of implantation on the weights of the ventral prostate and seminal vesicles. Prostate (1984) 0.88
Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears. J Clin Pathol (1991) 0.88
Primary megaureter: current trends in diagnosis and treatment. BJU Int (2000) 0.88
Determination of the proliferative fraction of a transplantable, hormone-dependent, human prostatic carcinoma (PC-82) by monoclonal antibody Ki-67: potential application for hormone therapy monitoring. J Natl Cancer Inst (1987) 0.87
Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. Urol Res (1995) 0.87
Etiological studies of severe or familial hypospadias. J Urol (2001) 0.87
The genetic make-up of renal cell tumors. Urol Res (2004) 0.87
Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate (2000) 0.87
Expression of cellular oncogenes in human prostatic carcinoma cell lines. Biochem Biophys Res Commun (1985) 0.87
The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomy. Int J Cancer (1995) 0.86
The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma. Br J Cancer (2001) 0.86
Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region. Lab Invest (2000) 0.86
Identification of a gene on human chromosome 8q11 that is differentially expressed during prostate-cancer progression. Int J Cancer (1999) 0.86
Decreased expression of CD44 in metastatic prostate cancer. Int J Cancer (1999) 0.86
Assessment of the critical level of androgen for growth response of transplantable human prostatic carcinoma (PC-82) in nude mice. J Urol (1991) 0.86
Kinetics of neuroendocrine differentiation in an androgen-dependent human prostate xenograft model. Am J Pathol (1999) 0.86
Serum free prostate specific antigen: isoenzymes in benign hyperplasia and cancer of the prostate. Prostate (1995) 0.84
Application of the monoclonal antibody Ki-67 on prostate biopsies to assess the fraction of human prostatic carcinoma. J Urol (1991) 0.84
Endoanal MRI of the anal sphincter complex: correlation with cross-sectional anatomy and histology. J Anat (1996) 0.83
Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective. BJU Int (2001) 0.83
Vesicoureteric reflux and videourodynamic studies: results of a prospective study after three years of follow-up. Urology (1994) 0.82
Immunohistochemical evaluation of the expression of prostate tumor-association markers in the nude mouse human prostate carcinoma heterotransplant lines PC-82, PC-EW, and PC-EG. Prostate (1990) 0.82
Vesicoureteral reflux and videourodynamic studies: results of a prospective study. Urology (2000) 0.81
Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues. Br J Cancer (2000) 0.81
Biological effects of hormonal treatment regimens on a transplantable human prostatic tumor line (PC-82). J Urol (1984) 0.81
Effects of adrenal androgens on the transplantable human prostate tumor PC-82. Endocrinology (1992) 0.81
Effect of parenteral testosterone therapy on penile development in boys with hypospadias. Br J Urol (1993) 0.81
The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patients. J Urol (1997) 0.81
Resistive index in obstructive uropathy. Br J Urol (1997) 0.81
Androgen receptor immunoexpression in the testes of subfertile men. J Androl (1997) 0.80
Administration of an LHRH-antagonist to male mice: effects on in vivo secretion of hormones and on the growth of a transplantable human prostatic carcinoma. Life Sci (1987) 0.80
Progress of fundamental research in Wilms' tumor. Urol Res (1997) 0.79
Recent advances in the development of animal and cell culture models for prostate cancer research A minireview. Urol Oncol (2011) 0.79
Partial ureteral obstruction: role of renal resistive index in stages of obstruction and release. Urology (1997) 0.79
E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ. Cancer Res (2000) 0.78
Human prostate cancer (PC-82) in nude mice: a model to study androgen regulated tumor growth. Prog Clin Biol Res (1985) 0.78
Ki-67 expression and BrdUrd incorporation as markers of proliferative activity in human prostate tumour models. Cell Prolif (1993) 0.78
Measurement of urinary flow rate using ultrasound in young boys and infants. J Urol (2001) 0.77
Partial ureteral obstruction: effect of intravenous normal saline and furosemide upon the renal resistive index. J Urol (1997) 0.77
Regulation of androgen receptor expression in the human heterotransplantable prostate carcinoma PC-82. Endocrinology (1992) 0.77
Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor. Urol Res (1992) 0.77
Inflammatory myofibroblastic tumour of the lung manifesting as progressive atelectasis. Pediatr Radiol (1999) 0.77
Characterization of androgen receptors in a transplantable human prostatic adenocarcinoma (PC-82). Prostate (1987) 0.77
Characterization of chromosome 8 aberrations in the prostate cancer cell line LNCaP-FGC and sublines. Urol Res (1999) 0.77
Partial ureteric obstruction: a study of Doppler ultrasonography and diuretic renography in different grades and durations of obstruction. Br J Urol (1996) 0.77
Characterization of androgen receptors after photoaffinity labelling with [3H]methyltrienolone (R1881). J Steroid Biochem (1986) 0.77
Cellular membrane associated mucins in artificial urine as mediators of crystal adhesion: an in vitro enterocystoplasty model. J Urol (2001) 0.77
Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinoma. J Cancer Res Clin Oncol (1995) 0.76
The cytocidal effect of high energy shock waves on human prostatic tumour cell lines. Eur J Cancer Clin Oncol (1989) 0.76
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissues. Prostate (1995) 0.76
Expression of HLA-like structures on a permanent human tumor line PC-93. Tissue Antigens (1983) 0.76
Takayasu's arteritis: a rare cause of cardiac death in a Caucasian teenage female patient. Neth J Med (1997) 0.75
Hormone receptors in human prostate cancer. Scand J Urol Nephrol Suppl (1988) 0.75